Longitudinal MRI monitoring of brain damage in the neonatal ventral hippocampal lesion rat model of schizophrenia

Hippocampus

Volumn 20, Issue 2, 2010, Pages 264-278

  Bertrand, Jean Baptiste ^a,b   Langlois, Jean Baptiste ^a,c   Bégou, Mélina ^a,b   Volle, Julien ^a,b   Brun, Philippe ^a,b   D'Amato, Thierry ^a,b   Saoud, Mohamed ^a,b   Suaud Chagny, Marie Françoise ^a,b  

^a Institut Federatif des Neurosciences de Lyon   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CERMEP IMAGERIE DU VIVANT   (France)

Author keywords

Ibotenic acid; Lesion criteria; MRI; Ventral hippocampus; Volumetric measurement

Indexed keywords

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; HIPPOCAMPUS; HISTOLOGY; IN VIVO STUDY; LOCOMOTION; LONGITUDINAL STUDY; MALE; MONITORING; NEWBORN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SCHIZOPHRENIA; VALIDATION PROCESS;

AGING; AMPHETAMINE; ANIMALS; ANIMALS, NEWBORN; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MOTOR ACTIVITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA;

EID: 75149186631     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20628     Document Type: Article

References (53)

1. Ashe PC, Chlan-Fourney J, Juorio AV, Li X. 2002. Brain-derived neurotrophic factor (BDNF) mRNA in rats with neonatal ibotenic acid lesions on the ventral hippocampus. Brain Res 956:126-135.
2. Ben-Horin N, Hazvi S, Bendel P, Schul R. 1996. The ontogeny of a neurotoxic lesion in rat brain revealed by combined MRI, histology. Brain Res 718:97-104.
3. Benveniste H, Blackband S. 2002. MR microscopy and high resolution small animal MRI: Applications in neuroscience research. Prog Neurobiol 67:393-420.
4. Bouilleret V, Nehlig A, Marescaux C, Namer IJ. 2000. Magnetic resonance imaging follow-up of progressive hippocampal changes in a mouse model of mesial temporal lobe epilepsy. Epilepsia 41:642-650.
5. Brockmann MA, Kemmling A, Groden C. 2007. Current issues and perspectives in small rodent magnetic resonance imaging using clinical MRI scanners. Methods 43:79-87.
6. Brun P, Begou M, Andrieux A, Mouly-Badina L, Clerget M, Schweitzer A, Scarna H, Renaud B, Job D, Suaud-Chagny MF. 2005. Dopaminergic transmission in STOP null mice. J Neurochem 94:63-73.
7. Chambers RA, Taylor JR. 2004. Animal modeling dual diagnosis schizophrenia: Sensitization to cocaine in rats with neonatal ventral hippocampal lesions. Biol Psychiatry 56:308-316.
8. Conroy SK, Rodd Z, Chambers A. 2006. Ethanol sensitization in a neurodevelopmental lesion model of schizophrenia in rats. Pharmacol Biochem Behav 86:386-394.
9. De Bellis MD, Keshavan MS, Beers SR, Hall J, Frustaci K, Masalehdan A, Noll J, Boring AM. 2001. Sex differences in brain maturation during childhood and adolescence. Cereb Cortex 11:552-557.
10. Flores G, Alquicer G, Silva-Gomez AB, Stewart J, Quirion R, Srivastava LK. 2005. Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience 133:463-470.
11. Geyer M, Moghaddam B. 2002. Animal models relevant to schizophrenia. In Neuropsychopharmacology: In: Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia: Lippincott Williams and Wilkins. pp 689-701.
12. Goto Y, O'Donnell P. 2004. Prefrontal lesion reverses abnormal mesoaccumbens response in an animal model of schizophrenia. Biol Psychiatry 55:172-176.
13. Grace AA. 2000. Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Rev 31:330-341.
14. Guzman R, Lövblad KO, Meyer M, Spenger C, Schroth G, Widmer HR. 2000. Imaging the rat brain on a 1.5 T clinical MR-scanner. J Neurosci Methods 97:77-85.
15. Hauss-Wegrzyniak B, Galons JP, Wenk GL. 2000. Quantitative volumetric analyses of brain magnetic resonance imaging from rat with chronic neuroinflammation. Exp Neurol 165:347-354.
16. Jarrard LE. 1989. On the use of ibotenic acid to lesion selectively different components of the hippocampal formation. J Neurosci Methods 29:251-259.
17. John J, Govindaraju V, Raghunathan P, Kumar VM. 1996. Magnetic resonance imaging of temporal changes of neurotoxic lesion in the rat. Brain Res Bull 40:273-277.
18. Johnson K, Ryan L, Davis J, Elmore A, Guenther B, Marcus J, Maronpot RR. 2006. Application of magnetic resonance imaging in developmental neurotoxicity testing: A pilot study. Neurotoxicology 27:846-851.
19. Kato K, Shishido T, Ono M, Shishido K, Kobayashi M, Suzuki H, Nabeshima T, Furukawa H, Niwa S. 2000. Effects of phencyclidine on behavior and extracellular levels of dopamine and its metabolites in neonatal ventral hippocampal damaged rats. Psychopharmacology 150:163-169.
20. Kohler C, Schwarcz R. 1983. Comparison of ibotenate and kainate neurotoxicity in the rat brain: A histological study. Neuroscience 8:819-835.
21. Le Pen G, Gaudet L, Mortas P, Mory R, Moreau JL. 2002. Deficits in reward sensitivity in a neurodevelopmental rat model of schizophrenia. Psychopharmacology 161:434-441.
22. Le Pen G, Grottick AJ, Higgins GA, Moreau JL. 2003. Phencyclidine exacerbates attentional deficits in a neurodevelopmental rat model of schizophrenia. Neuropsychopharmacology 28:1799-1809.
23. Le Pen G, Gourevitch R, Hazane F, Hoareau C, Jay TM, Krebs MO. 2006. Peri-pubertal maturation after developmental disturbance: A model for psychosis onset in the rat. Neuroscience 143:395-405.
24. Lewis DA, Levitt P. 2002. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25:409-432.
25. Lewis DA, Lieberman JA. 2000. Catching up on schizophrenia: Natural history and neurobiology. Neuron 28:325-334.
26. Lipska BK. 2004. Using animal models to test a neurodevelopmental hypothesis of schizophrenia. J Psychiatry Neurosci 29:282-286.
27. Lipska BK, Jaskiw GE, Weinberger DR. 1993. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia. Neuropsychopharmacology 9:67-75.
28. Lipska BK, Al-Amin HA, Weinberger DR. 1998. Excitotoxic lesions of the rat medial prefrontal cortex. Neuropsychopharmacology 19:451-464.
29. Lipska BK, Aultman JM, Verma A, Weinberger DR, Moghaddam B. 2002. Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology 27:47-54.
30. Lipska BK, Lerman DN, Khaing ZZ, Weinberger DR. 2003. The neonatal ventral hippocampal lesion model of schizophrenia: Effects on dopamine and GABA mRNA markers in the rat striatum. Eur J Neurosci 18:3097-3104.
31. Macaya A, Munell F, Gubits RM, Burke RE. 1994. Apopotosis in substantia nigra following striatal excitotoxic injury. Proc Natl Acad USA 91:8117-8121.
32. Malkova L, Lex CK, Mishkin M, Saunders R. 2001. MRI-based evaluation of locus and extent of neurotoxic lesions in monkeys. Hippocampus 11:361-370.
33. Markowska A, Bakke MK, Walther B, Ursin H. 1985. Comparison of electrolytic and ibotenic acid lesions in the lateral hypothalamus. Brain Res 328:313-323.
34. Marquis JP, Goulet S, Dore F. 2006. Neonatal lesions of the ventral hippocampus in rats lead to prefrontal cognitive deficits at two maturational stages. Neuroscience 140:759-767.
35. Martin LJ, Al-Abdulla NA, Brambrink AM, Kirsch JR, Sieber FE, Portera-Cailliau C. 1998. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Res Bull 46:281-309.
36. Namer IJ, Steibel J, Klinguer C, Trifilieff E, Mohr M, Poulet P. 1998. Magnetic resonance imaging of PLP-induced experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 92:22-28.
37. Nemanic S, Alvarado MC, Price RE, Jackson EF, Bachevalier J. 2002. Assessment of locus and extent of neurotoxic lesions in monkeys using neuroimaging techniques: A replication. J Neurosci Methods 121:199-209.
38. O'Donnell P, Lewis BL, Weinberger DR, Lipska BK. 2002. Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats. Cerebral Cortex 12:975-982.
39. Paxinos G, Watson C. 2005. The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press.
40. Richtand NM, Taylor B, Welge JA, Ahlbrand R, Ostrander MM, Burr J, Hayes S, Coolen LM, Pritchard LM, Logue A, Herman JP, McNamara RK. 2006. Risperidone treatment prevents elevated locomotor activity following neonatal hippocampal lesions. Neuropsychopharmacology 31:77-89.
41. Risterucci C, Jeanneau K, Schöppenthau S, Bielser T, Künnecke B, von Kienlin M, Moreau JL. 2005. Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia. Psychopharmacology 180:724-734.
42. Roch C, Leroy C, Nehlig A, Namer IJ. 2002. Magnetic resonance imaging in the study of the lithium-pilocarpine model of temporal lobe epilepsy in adult rats. Epilepsia 43:325-335.
43. Sams-Dodd F, Lipska BK, Weinberger DR. 1997. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology 132:303-310.
44. Spear LP. 2000. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24:417-463.
45. Stine CD, Lu W, Wolf ME. 2001. Expression of AMPA receptor flip and flop mRNAs in the nucleus accumbens and prefrontal cortex after neonatal ventral hippocampal lesions. Neuropsychopharmacology 24:253-266.
46. Suaud-Chagny MF. 2004. In vivo monitoring of dopamine overflow in the central nervous system by amperometric techniques combined with carbon fibre electrodes. Methods 33:322-329.
47. Swerdlow NR, Halim N, Hanlon FM, Platten A, Auerbach PP. 2001. Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: More is less. Brain Res Bull 55:71-77.
48. Tseng KY, Lewis BK, O'Donnell P. 2007. Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia. Biol Psychiatry 62:730-738.
49. Walker E, Bollini AM. 2002. Pubertal neurodevelopment and the emergence of psychotic symptoms. Schizophr Res 54:17-23.
50. Weinberger DR, Lipska BK. 1995. Cortical maldevelopment, antipsychotic drugs and schizophrenia: A search for a common ground. Schizophr Res 16:87-110.
51. Wolf OT, Dyakin V, Vadasz C, de Leon MJ, McEwen BS, Bulloch K. 2002a. Volumetric measurement of the hippocampus, the anterior cingulate cortex, and the retrosplenial granular cortex of the rat using structural MRI. Brain Res Protocols 10:41-46.
52. Wolf OT, Dyakin V, Patel A, Vadasz C, de Leon MJ, McEwen BS, Bulloch K. 2002b. Volumetric structural magnetic resonance imaging (MRI) of the rat hippocampus following kainic acid (KA) treatment. Brain Res 934:87-96.
53. Wood GK, Lipska BK, Weinberger DR. 1997. Behavioral changes in rats with early ventral hippocampal damage vary with age at damage. Brain Res Dev Brain Res 101:17-25.